Autologous stem cell transplantation


Harvesting of the patient’s own blood stem cells for quality control and storage is followed by high dosage treatment with chemotherapeutics and replacement of the harvested (=autologous) stem cells. The harvesting and transplantation is carried out after initial treatment with chemotherapeutics at the referring department.


Myeloma in patients under 65 as a primary therapy for different types of malignant lymphomas in various stages.

Treatment results

Myeloma - very good. No treatment mortality after 17 years of treatments. Autologous stem cell transplantation for myeloma is unfortunately not curative, but the treatment can be repeated once or twice.

Lymphoma - an evaluation is ongoing at the Department of Oncology.

Waiting times

Waiting times are very short: weeks up to a month. The planning of harvest and autologous stem cell transplantation often starts when the primary treatment at the referring department is initiated.



Evaluation by a specialized dentist is recommended before autologous stem cell transplantation, as it is useful to know whether there are potential foci of infection  in the oral cavity. 

Page revised Wednesday, February 15, 2012

Content manager: Olle Linder

Published by Mia Lagerroos


Head of unit

Olle Linder
Phone: +46 (0)19 602 17 83